• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有作为 P-糖蛋白抑制剂的人参皂苷的环丙沙星聚合物胶束通过 Caco-2 细胞单层的通透性研究-一种肠道吸收模型。

Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model.

机构信息

Nanotechnology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Golestan Ave, Ahvaz 67123, Iran.

出版信息

Molecules. 2018 Jul 31;23(8):1904. doi: 10.3390/molecules23081904.

DOI:10.3390/molecules23081904
PMID:30065147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6222528/
Abstract

The low oral bioavailability of ciprofloxacin is associated with two distinct challenges: its low aqueous solubility and efflux by p-glycoproteins (P-gp) in the intestinal membrane. Several studies were conducted in order to improve its solubility and permeability through the gastrointestinal membrane. In this study, in a full factorial design study, eight polymeric micelles were prepared and their characteristics, including particle size, loading and release rate were evaluated. Polymeric micelles demonstrated particle sizes below 190 nm and 27⁻88% loading efficiency. Drug release was affected by drug solubility, polymeric micelle erosion and swelling in simulated gastrointestinal fluids. An optimized polymeric micelle was prepared based on appropriate characteristics such as high drug loading and low particle size; and was used for a permeation study on Caco-2 cells. Optimized polymeric micelles with and without ginsenoside and ginsenoside alone enhanced drug permeability through Caco-2 cells significantly in the absorptive direction. The effect of ginsenoside was dose dependent and the maximum effect was seen in 0.23 mg/mL concentration. Results showed that P-gp may not be responsible for ciprofloxacin secretion into the gut. The main mechanism of ciprofloxacin transport through Caco-2 cells in both directions is active diffusion and P-gp has inhibitory effects on ciprofloxacin permeability in the absorptive direction that was blocked by ginsenoside and micelles without ginsenoside.

摘要

环丙沙星的口服生物利用度低与其面临的两个独特挑战有关

其在水中的溶解度低,以及在肠膜中被 P-糖蛋白(P-gp)外排。为了提高其在胃肠道膜中的溶解度和通透性,已经进行了多项研究。在这项研究中,采用完全因子设计研究方法制备了 8 种聚合物胶束,并对其特性(包括粒径、载药量和释放率)进行了评估。聚合物胶束的粒径均低于 190nm,载药量为 27-88%。药物释放受到药物溶解度、聚合物胶束在模拟胃肠道液体中的侵蚀和溶胀的影响。基于适当的特性(如高载药量和低粒径),制备了一种优化的聚合物胶束,并用于 Caco-2 细胞的渗透研究。载有和未载人参皂苷以及单独人参皂苷的优化聚合物胶束显著增强了药物在吸收方向上通过 Caco-2 细胞的渗透性。人参皂苷的作用具有剂量依赖性,在 0.23mg/mL 浓度下达到最大效果。结果表明,P-gp 可能不是将环丙沙星分泌到肠道中的原因。环丙沙星在两个方向上通过 Caco-2 细胞的主要传输机制是主动扩散,P-gp 对吸收方向中环丙沙星的通透性具有抑制作用,而人参皂苷和无人参皂苷的胶束则可以阻断这种抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/5dac8cbe9f0b/molecules-23-01904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/f9da361b0e26/molecules-23-01904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/c69c4da8e155/molecules-23-01904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/5dac8cbe9f0b/molecules-23-01904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/f9da361b0e26/molecules-23-01904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/c69c4da8e155/molecules-23-01904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/728d/6222528/5dac8cbe9f0b/molecules-23-01904-g003.jpg

相似文献

1
Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model.载有作为 P-糖蛋白抑制剂的人参皂苷的环丙沙星聚合物胶束通过 Caco-2 细胞单层的通透性研究-一种肠道吸收模型。
Molecules. 2018 Jul 31;23(8):1904. doi: 10.3390/molecules23081904.
2
Sirolimus-loaded polymeric micelles with honokiol for oral delivery.负载西罗莫司并含有厚朴酚的聚合物胶束用于口服给药。
J Pharm Pharmacol. 2015 Dec;67(12):1663-72. doi: 10.1111/jphp.12482. Epub 2015 Oct 10.
3
Evaluation of intestinal permeation enhancement with carboxymethyl chitosan-rhein polymeric micelles for oral delivery of paclitaxel.羧甲基壳聚糖-大黄素聚合物胶束口服递药系统对肠道通透性的评价。
Int J Pharm. 2020 Jan 5;573:118840. doi: 10.1016/j.ijpharm.2019.118840. Epub 2019 Nov 9.
4
Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin.纳米胶束制剂提高水飞蓟宾的溶解度和口服吸收。
Molecules. 2019 Apr 30;24(9):1688. doi: 10.3390/molecules24091688.
5
Supersaturated polymeric micelles for oral cyclosporine A delivery.用于口服环孢素 A 递送的超饱和聚合物胶束。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1325-36. doi: 10.1016/j.ejpb.2013.08.003. Epub 2013 Aug 13.
6
Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.基于 N-辛基-N'-邻苯二甲酰基-O-磷酸化壳聚糖衍生物的自组装胶束作为紫杉醇的有效口服载体。
Carbohydr Polym. 2019 Mar 1;207:428-439. doi: 10.1016/j.carbpol.2018.11.099. Epub 2018 Dec 6.
7
Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.以 Solutol HS15 和 Pluronic F127 为载体制备并评价淫羊藿次苷 II 载双体混合胶束
Drug Deliv. 2016 Nov;23(9):3248-3256. doi: 10.3109/10717544.2016.1167270. Epub 2016 Apr 11.
8
Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.通过深入了解其吸收和外排机制来提高 20(S)-人参皂苷 Rh2 的口服生物利用度。
Drug Metab Dispos. 2011 Oct;39(10):1866-72. doi: 10.1124/dmd.111.040006. Epub 2011 Jul 14.
9
Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.P-糖蛋白介导的分泌在药物吸收性通透性中的作用:一种利用被动膜通透性和对P-糖蛋白亲和力的方法。
J Pharm Sci. 1999 Oct;88(10):1067-72. doi: 10.1021/js980378j.
10
Enhanced oral delivery and anti-gastroesophageal reflux activity of curcumin by binary mixed micelles.通过二元混合胶束增强姜黄素的口服传递和抗胃食管反流活性。
Drug Dev Ind Pharm. 2019 Sep;45(9):1444-1450. doi: 10.1080/03639045.2019.1628041. Epub 2019 Jun 20.

引用本文的文献

1
Folic acid grafted mixed polymeric micelles as a targeted delivery strategy for tamoxifen citrate in treatment of breast cancer.叶酸接枝混合聚合物胶束作为柠檬酸他莫昔芬治疗乳腺癌的靶向递送策略。
Drug Deliv Transl Res. 2024 Apr;14(4):945-958. doi: 10.1007/s13346-023-01443-3. Epub 2023 Oct 31.
2
Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline.使用左氧氟沙星、环丙沙星、半缩醛酯前药和四环素对乙二胺四乙酸(EDTA)处理的兔子进行螯合药物生物利用度研究的开发与评估。
Pharmaceutics. 2023 May 24;15(6):1589. doi: 10.3390/pharmaceutics15061589.
3

本文引用的文献

1
Functionalized Polymers for Enhance Oral Bioavailability of Sensitive Molecules.用于提高敏感分子口服生物利用度的功能化聚合物。
Polymers (Basel). 2016 Jun 2;8(6):214. doi: 10.3390/polym8060214.
2
Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (LMDDs) for improving the therapeutic efficacy and reducing systemic toxicity.载多西紫杉醇的卵磷脂稳定胶束给药系统(LMDDs)的研制及其特性研究,旨在提高治疗效果,降低全身毒性。
Eur J Pharm Biopharm. 2018 Feb;123:9-19. doi: 10.1016/j.ejpb.2017.11.006. Epub 2017 Nov 14.
3
Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.
Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes.
用于递送环丙沙星以对抗多重耐药微生物的不同纳米技术方法。
Infect Drug Resist. 2022 Feb 5;15:413-426. doi: 10.2147/IDR.S348643. eCollection 2022.
4
Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.口腔纳米抗生素在细菌性感染治疗中的最新进展。
Int J Nanomedicine. 2020 Dec 1;15:9587-9610. doi: 10.2147/IJN.S279652. eCollection 2020.
5
Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.载奥沙利铂固体剂型的口服吸收和抗癌疗效的改善:在大鼠和非人灵长类动物中的药代动力学特性和口服节拍式给药对结直肠癌的影响。
Int J Nanomedicine. 2020 Oct 9;15:7719-7743. doi: 10.2147/IJN.S267424. eCollection 2020.
6
Lipid Membranes as Key Targets for the Pharmacological Actions of Ginsenosides.脂质膜作为人参皂苷药理作用的关键靶点。
Front Pharmacol. 2020 Sep 11;11:576887. doi: 10.3389/fphar.2020.576887. eCollection 2020.
7
Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy.口服培美曲塞用于节拍化疗的抗血管生成作用
Pharmaceutics. 2019 Jul 13;11(7):332. doi: 10.3390/pharmaceutics11070332.
环丙沙星固体脂质纳米粒:表征、体外释放及抗菌活性评估
Biomed Res Int. 2017;2017:2120734. doi: 10.1155/2017/2120734. Epub 2017 Jan 17.
4
Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.通过新型口服给药系统提高紫杉醇的生物利用度:载紫杉醇的甘草酸胶束
Molecules. 2015 Mar 6;20(3):4337-56. doi: 10.3390/molecules20034337.
5
Self-assembly micelles with lipid core of cholesterol for docetaxel delivery to B16F10 melanoma and HepG2 cells.具有胆固醇脂质核心的自组装胶束用于将多西他赛递送至B16F10黑色素瘤细胞和HepG2细胞。
J Liposome Res. 2015;25(2):157-65. doi: 10.3109/08982104.2014.961022. Epub 2014 Oct 2.
6
Self-assembled micelles composed of doxorubicin conjugated Y-shaped PEG-poly(glutamic acid)2 copolymers via hydrazone linkers.由通过腙连接子与阿霉素共轭的 Y 形聚乙二醇-聚谷氨酸2共聚物组成的自组装胶束。
Molecules. 2014 Aug 11;19(8):11915-32. doi: 10.3390/molecules190811915.
7
Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.草药成分对 P-糖蛋白的体外和体内抑制作用:通过 P-糖蛋白介导的药物-草药相互作用。
Toxicol Appl Pharmacol. 2014 Mar 1;275(2):163-75. doi: 10.1016/j.taap.2013.12.015. Epub 2013 Dec 29.
8
P-glycoprotein Inhibition for Optimal Drug Delivery.P-糖蛋白抑制作用以实现最佳药物递送。
Drug Target Insights. 2013 Aug 19;7:27-34. doi: 10.4137/DTI.S12519.
9
Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.聚合物胶束是一种很有前景的药物递送系统,可提高难溶性药物的生物利用度。
J Drug Deliv. 2013;2013:340315. doi: 10.1155/2013/340315. Epub 2013 Jun 27.
10
Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.普朗尼克P123/F127嵌段共聚物抑制P-糖蛋白介导的外排的机制:共聚物浓度与抑制活性之间的关系
Eur J Pharm Biopharm. 2013 Feb;83(2):266-74. doi: 10.1016/j.ejpb.2012.09.014. Epub 2012 Oct 23.